Vetera Gold XP Vaccine
(Flu/Rhino/EWT/WN) BI
${{ price | formatMoney }}
${{ min_price | formatMoney }} - ${{ max_price | formatMoney }}
select options to see price
Added to your cart!
View Cart / Checkout
Additional Shipping
This product does not qualify for free shipping, an additional $15.00 will be applied per item to your shipping upon checkout.
Requires Refrigeration
This product requires refrigeration, and must be shipped overnight.
Out of stock
Product Description
-
VETERA® GOLDXP is the industry's #1 vaccine1
-
VETERA® GOLDXP has been shown to be effective for the vaccination of healthy horses 4 months of age or older, including pregnant mares, against:
-
Eastern and western encephalomyelitis (EEE & WEE)
-
West nile virus (WNV)
-
Tetanus
-
Respiratory disease due to equine herpes virus types 1 and 4 (EHV-1 & EHV-4)
-
Equine influenza virus (EIV)
-
-
VETERA® GOLDXP has also been shown to be effective against viral shedding due to A2 EIV and against viremia, mortality, and neurological clinical disease due to WNV
-
The VETERA® portfolio features a wide range of progressive choices and contains the most comprehensive 1 mL vaccine (VETERA® GOLDXP + VEE) on the US market
-
VETERA® was the first vaccine in the US updated to contain both Florida sublineage clade 1 and clade 2 EIV, as recommended by the Expert Surveillance Panel (OIE) on Equine Influenza and AAEP
Features
-
Contains a combination of various antigens in one vaccine
-
Influenza
-
Herpesvirus types 1 and 4 (EHV-1 and EHV-4)
-
West Nile Virus (WNV)
-
Eastern and Western Equine Encephalomyelitis (EEE and WEE)
-
Tetanus
-
-
Contains Kentucky lineage (KY/95), Florida sublineage clade 1 (OH/03), and Florida sublineage clade 2 (RI/07) equine influenza strains
-
Contains EHV-1 and EHV-4
-
Includes a unique North American Equine E159™ WNV strain
-
Incorporates the Carbimmune® adjuvant formulation
-
Ultrafil® purification technology
Benefits
-
7-way protection in one vaccine
-
Carbimmune® adjuvant system allows a dual-phase antigen presentation to deliver both rapid and long-lasting immunity
-
Ultrafil® purification technology eliminates undesirable cellular components and extraneous protein to minimize the potential injection site reactions (such as heat, swelling, and inflammation)
-
At least 6-month duration of immunity against EIV (OH/03)
-
At least 12-month WNV duration of immunity
-
Safe for use in horses as young as 4 months of age, including pregnant mares
